Literature DB >> 6204963

Effect of oxygen concentration on pulmonary fibrosis caused by peplomycin in mice.

H Ekimoto, K Takada, K Takahashi, A Matsuda, T Takita, H Umezawa.   

Abstract

The pulmonary fibrosis caused by peplomycin (PEP) was studied in terms of oxygen toxicity using ICR mice. When 16 micrograms of PEP was administered intratracheally in mice after exposure to the air containing 75% O2 for 10 days, the pulmonary fibrosis was completely suppressed, while when mice were exposed to 75% O2 after the administration of PEP, the fibrosis was much severe than that of mice raised in atmospheric air. In 50% O2, similar oxygen effect was also observed, but it was weaker than that in 75% O2. In 90% O2, the oxygen toxicity was observed in mice without administration of PEP. When mice were exposed to 75% O2, the activities of superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase, which are relevant to the detoxication of active oxygen species, were not increased in the lung, but the levels of reducing agents such as glutathione and ascorbic acid, and high molecular substances having 1O2-scavenging activity were enhanced. The results suggest that these materials have some roles to decrease the pulmonary fibrosis caused by PEP.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204963     DOI: 10.7164/antibiotics.37.659

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Peplomycin, a bleomycin derivative, induces myofibroblasts in pulmonary fibrosis.

Authors:  T Osaki; K Yoneda; Y Tatemoto; T Yamamoto; T Yokoyama; H Enzan
Journal:  Int J Exp Pathol       Date:  2001-08       Impact factor: 1.925

2.  Contrasting influence of peplomycin and azelastine hydrochloride (Azeptin) on reactive oxygen generation in polymorphonuclear leukocytes, cytokine generation in lymphocytes, and collagen synthesis in fibroblasts.

Authors:  E Ueta; T Osaki; K Yoneda; T Yamamoto
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 3.  The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

Authors:  Antje Moeller; Kjetil Ask; David Warburton; Jack Gauldie; Martin Kolb
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.